Filing Details
- Accession Number:
- 0001053369-14-000006
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-01-06 17:49:02
- Reporting Period:
- 2013-11-15
- Filing Date:
- 2014-01-06
- Accepted Time:
- 2014-01-06 17:49:02
- Original Submission Date:
- 2013-11-14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1053369 | Elite Pharmaceuticals Inc | ELTP | Pharmaceutical Preparations (2834) | 223542636 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1442002 | Epic Pharma Llc | 227-15 North Conduit Ave Laurelton NY 11413-3134 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-11-15 | 253,050 | $0.12 | 72,950,493 | No | 4 | S | Indirect | By Epic Investments, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Epic Investments, LLC |
Footnotes
- The reporting person, Epic Pharma, LLC ("EP") owns 100% of the outstanding equity interests, is an equity owner of Epic Investments, LLC ("EI"). The interest of EP in the securities of the issuer owned by EI is limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.
- This amended form 4 is to correct the original Form 4/A filed on this same date to reflect the shares were disposed of and not acquired. The original Form 4/A was filed with an (A) in column 4 when the correct code is (D).
Billionaire Hedge Funds
